Showing 1,621 - 1,640 results of 47,816 for search '(( 50 ((we decrease) OR (mean decrease)) ) OR ( 16 ((nn decrease) OR (a decrease)) ))', query time: 0.84s Refine Results
  1. 1621
  2. 1622
  3. 1623
  4. 1624
  5. 1625
  6. 1626
  7. 1627
  8. 1628
  9. 1629
  10. 1630
  11. 1631

    AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial by Soraya Allas (4752756)

    Published 2018
    “…AZP-531, a first-in-class UAG analog, was shown to inhibit the orexigenic effect of AG in animals, to improve glycemic control and decrease body weight in humans. We aimed to investigate the safety and efficacy of AZP-531 in patients with PWS for whom no approved treatment for hyperphagia is currently available.…”
  12. 1632

    Substrate cross-links to TatA and TatC have comparable detection limits when substrate levels are gradually decreased. by Johannes Taubert (702534)

    Published 2015
    “…<p>Detection of cross-links of RR-HiPIP with <i>p</i>Bpa at position A13 (RR-A13<i>p</i>Bpa) either to wild-type level non-recombinant TatA in the absence of TatBC (left section: <i>tatAB</i><sup>-</sup><i>C</i><sup>-</sup>, strain JBdBC) or to wild-type level non-recombinant TatBC in the absence of TatA (right section: <i>tatA</i><sup>-</sup><i>BC</i>; strain JARV16). …”
  13. 1633
  14. 1634
  15. 1635
  16. 1636
  17. 1637
  18. 1638
  19. 1639
  20. 1640